OTHER NEWS - Nov. 3, 1994
- Share via
Painkiller Quickly Gains Popularity: Three months after its introduction, Aleve has become the No. 3 over-the-counter painkiller with U.S. consumers. Aleve, which claims to give relief for as long as 12 hours, went on sale in June. By mid-September, it had surpassed Excedrin and Bayer in sales, according to marketing statistics. Aleve still has a way to go before it challenges Advil and Tylenol, but its distributor, Procter & Gamble, says it already has roughly twice the market share Advil had just after it went on the shelf 10 years ago. Aleve had roughly 6.8% of the $2.5-billion-a-year painkiller market in the four weeks ended Sept. 11, according to figures compiled by research firm Information Resources Inc.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.